indole has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bommagani, S | 1 |
| Ponder, J | 1 |
| Penthala, NR | 1 |
| Janganati, V | 1 |
| Jordan, CT | 1 |
| Borrelli, MJ | 1 |
| Crooks, PA | 1 |
1 other study available for indole and Hematologic Malignancies
| Article | Year |
|---|---|
Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
Topics: Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Dose-Response Relatio | 2017 |